125.3K
Downloads
263
Episodes
Molecule to Market takes you inside the global pharma and biopharma outsourcing ecosystem. Each week, our host Raman Sehgal sits down with the founders, entrepreneurs, CEOs and C-suite leaders shaping the pharma services and tools that power discovery, drug development and commercialization.
Listeners get real stories and practical insights from across the entire value chain, from big pharma and emerging biotechs to private equity investors, CROs, CDMOs, technology platforms and specialist consulting firms. Our host Raman is an entrepreneur, investor, bestselling author, speaker and long time industry insider.
https://moleculetomarketpod.com
Episodes
Thursday Apr 01, 2021
Thursday Apr 01, 2021
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jeff Dill, CEO at Vynamic.
Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Jeff, covering:·
- How to create, document, grow and internationally scale an incredible business culture.
- The shift towards greater industry collaboration as an important step for quicker drug approvals in the future.
- Servant leadership philosophy - to listen, be empathetic and enable.
- The drive and transparency needed to create a more diverse and inclusive workforce.
Jeff boasts over 20 years’ experience in the healthcare consulting world. Previously at Accenture, Jeff joined healthcare industry management consulting firm Vynamic in 2005, he has been there ever since and is now the CEO.
Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating! Molecule to Market is sponsored and funded by ramarketing. An international content, design and digital agency that helps companies in life sciences, get noticed.
No comments yet. Be the first to say something!